Bodyport Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $11.2M
Latest Deal Amount
  • Investors
  • 10

Bodyport General Information

Description

Developer of a biomarker platform intended to detect early signs of cardiovascular disease. The company's platform with the help of proprietary sensor technology into a bathroom scale detects cardiac signals and biomarkers through a user's feet, powering algorithms that have the potential to predict risk, enabling care teams to assess the overall health status of their patients and flags deviations from each patient's individualized health baseline.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Media and Information Services (B2B)
Electronic Equipment and Instruments
Decision/Risk Analysis
Primary Office
  • 970 Folsom Street
  • San Francisco, CA 94107
  • United States

Bodyport Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bodyport Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 11-Aug-2020 $11.2M 000.00 000.00 Completed Generating Revenue
2. Seed Round 01-Apr-2018 00.000 00.00 000.00 Completed Generating Revenue
1. Accelerator/Incubator 18-Aug-2015 $120K $120K 00.000 Completed Generating Revenue
To view Bodyport’s complete valuation and funding history, request access »

Bodyport Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed 1 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Seed 4,941,976 $0.000010 $0.06 $0.93 $0.93 1x $9.28 2.44%
To view Bodyport’s complete cap table history, request access »

Bodyport Patents

Bodyport Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190046069-A1 Cardiovascular signal acquisition, fusion, and noise mitigation Pending 10-Jul-2015 0000000000
CA-2992038-A1 Device for measuring biological signals Pending 10-Jul-2015 0000000000
US-20190059761-A1 Cardiovascular health monitoring device Pending 10-Jul-2015 0000000000
US-20180199824-A1 Device for measuring biological signals Pending 10-Jul-2015 0000000000 0
US-20190046064-A1 Cardiovascular signal acquisition, fusion, and noise mitigation Pending 10-Jul-2015 A61B5/04085

Bodyport Executive Team (3)

Name Title Board Seat Contact Info
Corey Centen Co-Founder, Chief Executive Officer & Board Member
Amit Rushi Chief Commercial Officer
Sarah Smith Co-Founder, Chief Product Officer & Board Member
To view Bodyport’s complete executive team members history, request access »

Bodyport Board Members (6)

Name Representing Role Since
Bruce Leak Playground Global Board Member 000 0000
Corey Centen Bodyport Co-Founder, Chief Executive Officer & Board Member 000 0000
Debbie Lin Ph.D Boehringer Ingelheim Venture Fund Board Member 000 0000
Garry Tan Initialized Capital Management Board Member 000 0000
Phyllis Whiteley Ph.D Self Chairman of the Board 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Bodyport Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bodyport Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Regah Ventures Venture Capital Minority 000 0000 000000 0
Beth McClendon Angel (individual) Minority 000 0000 000000 0
Boehringer Ingelheim Venture Fund Venture Capital Minority 000 0000 000000 0
Hardware Club Venture Capital Minority 000 0000 000000 0
Initialized Capital Management Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »